Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Health care providers work at triage tents outside Providence St. Mary Medical Center in Southern California. Photo: Mario Tama/Getty Images
The Centers for Disease Control and Prevention warned Friday that the highly transmissible coronavirus variant first discovered in the U.K. will likely become the dominant strain in the U.S. this March if more steps aren't taken to mitigate the spread.
The state of play: Only about 76 people in a dozen states have been diagnosed with the the B.1.1.7 variant so far, according to the CDC, but experts warn there are likely more undetected cases. Although the variant is more contagious, it does not appear to be resistant to existing vaccines or cause more severe symptoms.
- Recent research by Public Health England found the B.1.1.7 variant is about 30%-50% more transmissible than other forms of the virus.
What they're saying: “The modeled trajectory of this variant in the U.S. exhibits rapid growth in early 2021, becoming the predominant variant in March,” according to the CDC study published Friday.
- "The increased transmissibility of the B.1.1.7 variant warrants rigorous implementation of public health strategies to reduce transmission and lessen the potential impact of B.1.1.7, buying critical time to increase vaccination coverage," the study added.
- "Currently, there is no known difference in clinical outcomes associated with the described SARS-CoV-2 variants; however, a higher rate of transmission will lead to more cases, increasing the number of persons overall who need clinical care, exacerbating the burden on an already strained health care system, and resulting in more deaths."
The big picture: Viruses mutate, often without impacting the severity of disease or how the virus spreads. But sometimes mutations are consequential for public health and scientists say it's important to monitor them, Axios' Marisa Fernandez reports.
- Officials worldwide are tracking the SARS-CoV-2 variants, including the B.1.1.7 variant, the 501.V2 variant in South Africa and a newly discovered variant in Brazil.
- Pfizer and Moderna are in the process of testing their vaccines against the variants. The pharmaceutical companies said Thursday the mutation N501Y found in both variants B.1.1.7 and 501.V2 was tested against their vaccine and found “no reduction in neutralization activity against the virus.”
- But there are multiple mutations and more studies are underway.
Go deeper: What you need to know about the coronavirus variants